 | • レポートコード：MRC2203A100 • 出版社/出版日：Mordor Intelligence / 2022年1月 • レポート形態：英文、PDF、112ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療 |
| Single User | ￥703,000 (USD4,750) | ▷ お問い合わせ |
| Site Licence | ￥962,000 (USD6,500) | ▷ お問い合わせ |
| Corporate License | ￥1,295,000 (USD8,750) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| Mordor Intelligence社の本市場調査レポートでは、世界の二酸化炭素インキュベーター市場について調査・分析し、イントロダクション、調査手法、エグゼクティブサマリー、市場動向、製品種類別（ウォータージャケットCO2インキュベーター、エアジャケットCO2インキュベーター、直接熱CO2インキュベーター、その他）分析、用途別（実験室研究・臨床用、体外受精、その他）分析、地域別（北米、ヨーロッパ、アジア太平洋、中東・アフリカ、南米）分析、競争状況、市場機会・将来傾向など、以下の構成でまとめました。 ・イントロダクション ・調査手法 ・エグゼクティブサマリー ・市場動向 ・世界の二酸化炭素インキュベーター市場規模：製品種類別（ウォータージャケットCO2インキュベーター、エアジャケットCO2インキュベーター、直接熱CO2インキュベーター、その他） ・世界の二酸化炭素インキュベーター市場規模：用途別（実験室研究・臨床用、体外受精、その他） ・世界の二酸化炭素インキュベーター市場規模：地域別（北米、ヨーロッパ、アジア太平洋、中東・アフリカ、南米） ・競争状況（Eppendorf AG、BINDER GmbH、Panasonic Healthcare Co.、…） ・市場機会・将来傾向 |
The carbon dioxide incubator market is expected to witness a CAGR of 7.9% over the forecast period.
The coronavirus outbreak is continuing to spread, with countries seeing a rise in the number of those affected. While most cases are mild, the virus has a fatality rate of between one and two percent. Scientists are working hard to develop a vaccine and relying on incubators as weapons in the fight. Cabron dioxide incubator is being used to store coronavirus samples to be retrieved whenever necessary and investigated to gain insights into this new respiratory disease. For example, some BINDER CO2 incubators capable of heating up to 180°C are already being used to reproduce dangerous infections on human cells to deliver new insights into SARS-CoV-2 (which causes coronavirus). Thus, the COVID-19 pandemic is expected to have a tremendous impact on the growth of the studied market.
The carbon dioxide incubator market is expected to show rapid growth due to the growing prevalence of infectious and chronic diseases, technological advancement in carbon dioxide incubator devices, and rising interest in stem cell and vaccine research.
Rapid innovation in automation along with the increasing investment in research and development in the biotechnology and life science sector from both government and private players and increasing awareness about the benefits associated with the carbon dioxide incubators among researchers are also expected to drive the growth of the market.
Carbon dioxide incubators are most prominently utilized in pharmaceutical, medical, and other related fields. This device is mostly used in the development of tissue-engineered products. For instance, at the University of Zurich, the Swiss Center for Regenerative Medicines (SCRM) utilizes CO2 incubators for research therapies based on tissue engineering, which comprises cell clusters and tissues. Also, it enables the growth of blood vessels and heart valves grown from stem cells. Such studies conducted by various research institutes and government organizations will create lucrative opportunities in the market, thereby supplementing the market growth.
In addition, the technological advancement in carbon dioxide incubators devices is considered the driver for the growth of the market. Moreover, the growing prevalence of crop and agriculture research in many regions is further expected to fuel the market’s growth. However, factors such as limitations associated with carbon dioxide incubators are likely to impede the market growth over the forecast period.
Key Market Trends
In Vitro Fertilizations by Application Segment are Expected to Dominate the Market During the Forecast Period
In vitro fertilization is an assistive reproductive technology, which involves the process of fertilization by retrieving eggs from the woman’s ovaries and fertilizing them with sperm outside the body, under a laboratory environment. The fertilization occurs outside of the body in an incubator under controlled conditions. The most commonly used environmental conditions for human IVF incubators are 5% CO2 in the air, 37°C, and 100% relative humidity. The increasing awareness of advanced in vitro fertilization (IVF) techniques, rising success rates of IVF, and disorders due to the delayed onset of pregnancy have stimulated the demand for in vitro fertilization, thereby boosting the demand for CO2 incubators across the world.
The proportion of women who are intentionally delaying pregnancies beyond the age of 35 years has been increasing in the past few years. According to the Center for Disease Control and Prevention (CDC), about 10% of women (6.1 million) in the United States aged between 15 -44 have difficulty in getting pregnant or staying pregnant each year. Also, a study by the Hebrew University of Jerusalem revealed that sperm counts for men have more than halved over the last 40 years. As per the UN World Fertility report 2019, rapid fertility declines were observed in 77 countries globally and areas where adolescent fertility declined by more than 50% between 1990-1995 and 2015-2020. In such cases, a CO2 incubator is necessary to maintain an optimal environment for cell growth by providing carbon dioxide control in a humidified atmosphere with a constant temperature. Thus, the aforementioned statistics indicate the high demand for carbon dioxide incubators in the coming future.
North America Accounted for the Largest Market Share of the Carbon Dioxide Incubators Market
North America accounted for the largest market share, which is attributed to the increasing research and development activities in the life science and biotechnology sectors and manufacturers in the carbon dioxide market focusing on offering the products on the basis of the specific and unique requirements. As per the SingleCare online Survey, conducted in October 2020, 20% of the respondents received in vitro fertilization (IVF) in the United States. Additionally, 19% of the respondents reported polycystic ovarian syndrome(PCOS), and 25% reported unknown reasons for infertility. Thus, the high incidence of infertility is driving the studied market growth.
Moreover, the strong foothold of key market players in the North American region is also likely to fuel the regional market growth. Thermo Fisher Scientific Inc., Panasonic Healthcare Co Ltd., Binder GmbH, and Bellco Glass are few major players operating in the arena of North American carbon dioxide incubators market share. In January 2019, Bellco Glass introduced its new range of 40 cubic feet volume of carbon dioxide incubators. These novel CO2 incubators also consist of a microprocessor temperature controller, safety thermostat, and control panel, which features dials for automatic control temperature and indicating lights. Such products launches will help the regional market to grow at a faster pace.
Competitive Landscape
The carbon dioxide incubator market is moderately competitive, owing to the presence of many small and large market players. The major participants in the global carbon dioxide market include Panasonic Healthcare Co Ltd, Bellco Glass Inc., Thermo Fisher Scientific Inc., Eppendorf AG, Sheldon Manufacturing Inc., Memmert GmbH+CoKG, and Binder GmbH. Thermo Electron and Fisher Scientific are gaining presence in the carbon dioxide incubator market by merger and acquisition route and are found investing in new technologies.
Additional Benefits:
- The market estimate (ME) sheet in Excel format
- 3 months of analyst support
1 INTRODUCTION
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Growing Prevalence of Infectious and Chronic Diseases
4.2.2 Technological Advancement in Carbon Dioxide Incubator Devices
4.2.3 Rising Interest in Stem Cell and Vaccine Research
4.3 Market Restraints
4.3.1 Limitations Associated with Carbon Dioxide Incubators
4.4 Porter’s Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION
5.1 By Product Type
5.1.1 Water Jacketed CO2 Incubators
5.1.2 Air Jacketed CO2 Incubators
5.1.3 Direct Heat CO2 Incubators
5.1.4 Other Product Types
5.2 By Application
5.2.1 Laboratory Research and Clinical Applications
5.2.2 In Vitro Fertilization
5.2.3 Other Applications
5.3 By Geography
5.3.1 North America
5.3.1.1 United States
5.3.1.2 Canada
5.3.1.3 Mexico
5.3.2 Europe
5.3.2.1 Germany
5.3.2.2 United Kingdom
5.3.2.3 France
5.3.2.4 Italy
5.3.2.5 Spain
5.3.2.6 Rest of Europe
5.3.3 Asia-Pacific
5.3.3.1 China
5.3.3.2 Japan
5.3.3.3 India
5.3.3.4 Australia
5.3.3.5 South Korea
5.3.3.6 Rest of Asia-Pacific
5.3.4 Middle-East and Africa
5.3.4.1 GCC
5.3.4.2 South Africa
5.3.4.3 Rest of Middle-East and Africa
5.3.5 South America
5.3.5.1 Brazil
5.3.5.2 Argentina
5.3.5.3 Rest of South America
6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Eppendorf AG
6.1.2 BINDER GmbH
6.1.3 Panasonic Healthcare Co.
6.1.4 Thermo Fisher Scientific Inc.
6.1.5 Sheldon Manufacturing Inc.
6.1.6 Shanghai Boxun Medical Biological Instrument Corp.
6.1.7 Bellco Glass
6.1.8 Memmert GmbH & Co.
6.1.9 LEEC corporation
7 MARKET OPPORTUNITIES AND FUTURE TRENDS